Quiz
Alzheimer Disease Treatment Types
News
04/23/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for memantine hydrochloride capsules due to failure to meet dissolution specifications.
The US Food and Drug Administration (FDA) has issued a Class II recall for memantine hydrochloride capsules due to failure to meet dissolution specifications.
The US Food and Drug...
04/23/2026
Pharmacy Learning Network
News
10/23/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for NAD+ due to elevated endotoxin levels, posing a serious risk of severe inflammatory reactions or sepsis if administered.
The US Food and Drug Administration (FDA) has issued a Class I recall for NAD+ due to elevated endotoxin levels, posing a serious risk of severe inflammatory reactions or sepsis if administered.
The US Food and Drug...
10/23/2025
Pharmacy Learning Network
Quiz
06/12/2025
True or False: Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are disease-modifying therapies that significantly delay the progression of early Alzheimer disease by reducing amyloid-beta accumulation.TrueFalse
True or False: Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are disease-modifying therapies that significantly delay the progression of early Alzheimer disease by reducing amyloid-beta accumulation.TrueFalse
True or False: Cholinesterase...
06/12/2025
Pharmacy Learning Network
Quiz
04/22/2025
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of...
04/22/2025
Pharmacy Learning Network
